Durata Therapeutics Enters Into an Exclusive License and Supply Agreement With Angelini to Commercialize Dalbavancin in Certain European Territories, Russia and Turkey Approximately $80M in Upfront and Milestone Payments CHICAGO, July 30, 2014 (GLOBE NEWSWIRE) —...
New Data on Chimerix’s Brincidofovir Supports Safety and Antiviral Activity Against Multiple Life-Threatening DNA Viruses in Organ Transplant Recipients Three Abstracts Presented at 2014 World Transplant Congress DURHAM, N.C., July 31, 2014 (GLOBE NEWSWIRE)...
Oxford Immunotec Announces Purchase Of Assets Of Boulder Diagnostics Inc. OXFORD, United Kingdom and MARLBOROUGH, Mass., August 5, 2014 (GLOBE NEWSWIRE) – Oxford Immunotec Global PLC (NASDAQ: OXFD), a global, commercial-stage diagnostics company committed to...
Kit Check Adds Medication Shortage Management Features To Improve Pharmacy Kit Processing Efficiency Washington, DC – August 6, 2014 – Kit Check™ (http://kitcheck.com), the leader in hospital pharmacy kit processing software, today announced new shortage management...
Spiracur Announces Renewal Contract with Novation for Advanced, Mechanically-Powered, Disposable Negative Pressure Wound Care Products SUNNYVALE, Calif., August 7, 2014 – Spiracur, the developer of the only mechanically powered advanced wound care solution that...
Concert Pharmaceuticals Achieves $2 Million Milestone for AVP-786 Under Avanir Pharmaceuticals Collaboration LEXINGTON, Mass.–(Aug 26, 2014)– Concert Pharmaceuticals, Inc. (NASDQ: CNCE) today announced that it has achieved a $2 million milestone under its...
Recent Comments